Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337831
Status:
COMPLETED
Last Update Posted:
2011-06-30
First Post:
2006-06-15
Brief Title:
Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment
Sponsor:
University Hospital Ghent
Organization:
University Hospital Ghent
Study Overview
Official Title:
Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients will be treated with hemodiafiltration HDF in postdilution mode as a control therapy during 9 weeks During week 5 the 1st intervention treatment predilution hemofiltration HF or predilution HDF will be performed as a midweek session After 4 additional weeks of control therapy the other intervention treatment will be performed Samples will be taken during week 4 5 and 9 from inlet blood flow 0 30 60 120 and 240 min from outlet blood flow and dialysate outflow 30 60 120 and 240 min
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None